MM+M Intelligence is an artificial intelligence assistant designed to help you navigate our comprehensive guide on medical ...
These Democrats would have to surmount political and legislative hurdles at a time when the realities of Medicaid expansion ...
The Fingerpaint founder is betting that sports can do more for healthcare marketers than put a pharmaceutical logo on a ...
Pharma has been rolling out lots of agentic AI pilots, but needs to incorporate the right metrics to move from speed to ...
As physicians increasingly turn to AI for answers, the OpenEvidence executive will unpack what happens when pharma's HCP ...
Oura’s telehealth acquisition muddies waters; Prostate cancer screening recommendations change for some men; Boston ...
Pharma marketers have more data, dashboards, research and AI tools than ever, yet getting to the insight that actually changes a decision can still take weeks.
Teva settles U.S. states' drug price-fixing case; FDA knocks potential Keytruda competitor; Johnson & Johnson acquires Ollin Biosciences for $2.2 billion upfront.
Researchers with direct knowledge told KFF Health News that the Pan American Health Organization reached the conclusion this ...
The rule didn’t set a standard process for states to prove Native American status, allowing states to raise the threshold for ...
The cold and flu brand more than doubled its estimated TV ad spend, while daytime programming nearly matched prime time’s ...
Drugmakers largely achieved solid topline results in Q3. The more interesting story related to their respective ad spends.